• Login
    View Item 
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    •   Home
    • The Christie Research Publications Repository
    • All Christie Publications
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Browse

    All of ChristieCommunitiesTitleAuthorsIssue DateSubmit DateSubjectsThis CollectionTitleAuthorsIssue DateSubmit DateSubjectsProfilesView

    My Account

    LoginRegister

    Local Links

    The Christie WebsiteChristie Library and Knowledge Service

    Statistics

    Display statistics

    Traditional phase 1 and 2 studies in thoracic radiation oncology should be abandoned.

    • CSV
    • RefMan
    • EndNote
    • BibTex
    • RefWorks
    Authors
    Faivre-Finn, Corinne
    Snee, M
    Affiliation
    Institute of Cancer Sciences, University of Manchester, Radiotherapy Related Research, The Christie NHS Foundation Trust, Manchester, United Kingdom.
    Issue Date
    2014-11-01
    
    Metadata
    Show full item record
    Citation
    Traditional phase 1 and 2 studies in thoracic radiation oncology should be abandoned. 2014, 90 (3):487-9 Int J Radiat Oncol Biol Phys
    Journal
    International Journal of Radiation Oncology, Biology, Physics
    URI
    http://hdl.handle.net/10541/333677
    DOI
    10.1016/j.ijrobp.2014.05.044
    PubMed ID
    25304944
    Type
    Article
    Language
    en
    ISSN
    1879-355X
    ae974a485f413a2113503eed53cd6c53
    10.1016/j.ijrobp.2014.05.044
    Scopus Count
    Collections
    All Christie Publications

    entitlement

    Related articles

    • Clinical trials in thoracic radiation oncology: as easy as 1, 2, 3.
    • Authors: Machtay M, Bradley JD, Curran WJ
    • Issue date: 2014 Nov 1
    • Pembrolizumab Outperforms Docetaxel for NSCLC.
    • Authors: Leslie M
    • Issue date: 2016 Mar
    • Concurrent chemoradiotherapy followed by consolidation chemotherapy with bi-weekly docetaxel and carboplatin for stage III unresectable, non-small-cell lung cancer: clinical application of a protocol used in a previous phase II study.
    • Authors: Saitoh J, Saito Y, Kazumoto T, Kudo S, Yoshida D, Ichikawa A, Sakai H, Kurimoto F, Kato S, Shibuya K
    • Issue date: 2012 Apr 1
    • Current status of and future strategies for multimodality treatment of unresectable stage III nonsmall cell lung cancer.
    • Authors: Huber RM, Reck M, Thomas M
    • Issue date: 2013 Oct
    • Is immune checkpoint inhibition part of standard therapy for stage III non-small cell lung cancer?
    • Authors: Patel JD, Chmura SJ
    • Issue date: 2018 Jul 15
    DSpace software (copyright © 2002 - 2025)  DuraSpace
    Quick Guide | Contact Us
    Open Repository is a service operated by 
    Atmire NV
     

    Export search results

    The export option will allow you to export the current search results of the entered query to a file. Different formats are available for download. To export the items, click on the button corresponding with the preferred download format.

    By default, clicking on the export buttons will result in a download of the allowed maximum amount of items.

    To select a subset of the search results, click "Selective Export" button and make a selection of the items you want to export. The amount of items that can be exported at once is similarly restricted as the full export.

    After making a selection, click one of the export format buttons. The amount of items that will be exported is indicated in the bubble next to export format.